Founder mutation for Huntington disease in Caucasus Jews

Clinical Genetics

Volumn 87, Issue 2, 2015, Pages 167-172

  Melamed, O ^a   Behar, D M ^a,b   Bram, C ^c   Magal, N ^a   Pras, E ^d,e   Reznik Wolf, H ^d   Borochowitz, Z U ^f,g   Davidov, B ^a   Mor Cohen, R ^d,e   Baris, H N ^a,e  

^a RABIN MEDICAL CENTER   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d SHEBA MEDICAL CENTER   (Israel)

^e TEL AVIV UNIVERSITY   (Israel)

^f BNAI ZION MEDICAL CENTER   (Israel)

^g TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Caucasus Jews; Founder mutation; Haplotype; Huntington disease

Indexed keywords

ADULT; AGED; ARTICLE; CAG REPEAT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOUNDER EFFECT; GENE FREQUENCY; GENE MUTATION; HAPLOGROUP; HAPLOTYPE; HUMAN; HUNTINGTON CHOREA; ISRAEL; ISRAELI; JEW; MALE; ONSET AGE; PREVALENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; CAUCASIAN; GENETICS; HETEROZYGOTE DETECTION; MIDDLE AGED; MUTATION; PEDIGREE; TRINUCLEOTIDE REPEAT;

HTT PROTEIN, HUMAN; NERVE PROTEIN;

ADULT; AGED; ALLELES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HAPLOTYPES; HETEROZYGOTE DETECTION; HUMANS; HUNTINGTON DISEASE; ISRAEL; JEWS; MALE; MIDDLE AGED; MUTATION; NERVE TISSUE PROTEINS; PEDIGREE; TRINUCLEOTIDE REPEATS;

EID: 84921438998     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/cge.12344     Document Type: Article

References (22)

1. Roos RA. Huntington's disease: a clinical review. Orphanet J Rare Dis 2010: 5 (1): 40.
2. Andrew SE, Goldberg YP, Kremer B et al. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nat Genet 1993: 4 (4): 398-403.
3. Semaka A, Creighton S, Warby S, Hayden MR. Predictive testing for Huntington disease: interpretation and significant of intermediate alleles. Clin Genet 2006: 70 (4): 283-294.
4. Telenius H, Kremer HP, Theilmann J et al. Molecular analysis of juvenile Huntington disease: the major influence on (CAG)n repeat length is the sex of the affected parent. Hum Mol Genet 1993: 2 (10): 1535-1540.
5. Harper PS. The epidemiology of Huntington's disease. Hum Genet 1992: 89 (4): 365-376.
6. Warby SC, Montpetit A, Hayden AR et al. CAG expansion in the Huntington disease gene is associated with a specific and targetable predisposing haplogroup. Am J Hum Genet 2009: 84 (3): 351-366.
7. Rannala B, Reeve JP. High-resolution multipoint linkage-disequilibrium mapping in the context of a human genome sequence. Am J Hum Genet 2001: 69 (1): 159-178.
8. Reeve JP, Rannala B. DMLE+: Bayesian linkage disequilibrium gene mapping. Bioinformatics 2002: 18 (6): 894-895.
9. Tults M. The interrelationship between emigration and the socio-demographic profile of Russian Jewry. In: Lewin-Epstein N, Roi Y, Ritterband P, eds. Russian Jews on three continents - migration and resettlement. London: Frank Cass, 1997: 147-176.
10. Bram C. Ethnic categorization and cultural diversity: "A view from the margins": Caucasus Jews between Europe and Asia. PhD Dissertation, the Hebrew University of Jerusalem, 2008.
11. Bram C. Immigrant Jews of the Caucasus in New York and Moscow: ethno-cultural identity and community organization. Sociol Pap 2009: 13: 43-57.
12. Magid DL. Everey na yuz'nakh Rossia, Veiposk I: Everei na Kavkaze, Istoricheskii ocherk. 1920. Cited in: Altshuler M. The Jews of the Eastern Caucasus: the history of the Mountain Jews from the beginning of the nineteenth century. Jerusalem: Ben Zvi Institute for the study of Jewish communities of the East - the Hebrew University of Jerusalem, 1990: 43 (Hebrew).
13. Olim BeYishuvim (immigrants in towns/municipalities - table), Israel Ministry for Immigrant Absorption, 2004.
14. Bram C. Shaping group identity during a migration process: Caucasus Jews and the Importance of "inner" diversity. Peamim 2007: 111-112, pp. 145-185 (Hebrew).
15. Bram C. Visibility processes, visibility agents, and social categorization. Lomsky-Feder E, Rapoport T, eds. Visibility in immigration: body, gaze, pepresentations. The Van Leer Jerusalem Institute and Hakibbutz Hameochad, Jerusalem 2010 (Hebrew).
16. Behar DM, Metspalu E, Kivisild T et al. Counting the founders: the matrilineal genetic ancestry of the Jewish Diaspora. PLoS One 2008: 3 (4): e2062.
17. Behar DM, Yunusbayev B, Metspalu M et al. The genome-wide structure of the Jewish people. Nature 2010: 466 (7303): 238-242.
18. Folstein SE, Leigh RJ, Parhad IM, Folstein MF. The diagnosis of Huntington's disease. Neurology 1986: 36 (10): 1279-1283.
19. Stewart JT. Misdiagnosis of Huntington's disease. J Neuropsychiatry Clin Neurosci 1989: 1 (1): 97.
20. Kozlova SI, Dadali EL, Prytkov AN, Bol'shakova LP, Sibiriakova LG. Population-demographic and clinico-genetic characteristics of Huntington chorea in one region of Azerbaijan. Genetika 1986: 22 (10): 2534-2539.
21. Altshuler M. The Jews of the Eastern Caucasus: the history of the Mountain Jews from the beginning of the nineteenth century. Jerusalem: Ben Zvi Institute for the study of Jewish communities of the East - the Hebrew University of Jerusalem, 1990: 44-47, 147-149 (Hebrew).
22. Warby SC, Visscher H, Collins JA et al. HTT haplotypes contribute to differences in Huntington disease prevalence between Europe and East Asia. Eur J Hum Genet 2011: 19 (5): 561-566.